Eledon Pharmaceuticals Stock Quote ELDN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.25

Bid

3.10

Ask

3.28

Volume

611,409

2.80 Day's Range 3.2884

1.07 52 Week Range 3.2884

Market Cap

73.32M

Previous Close

2.80

Open

2.80

Last Trade

3.12

Last Trade Time

Financial Volume

$ 1,874,345

VWAP

3.0656

Average Volume (3m)

173,240

Shares Outstanding

24,198,130

Dividend Yield

PE Ratio

-1.82

Earnings Per Share (EPS)

-1.67

Revenue

Net Profit

-40.33M

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eledon.com

Headquarters

Dover, Delaware, USA

Founded

1970

Eledon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELDN. The last closing price for Eledon Pharmaceuticals was $2.80. Over the last year, Eledon Pharmaceuticals shares have traded in a share price range of $ 1.07 to $ 3.2884.

Eledon Pharmaceuticals currently has 24,198,130 shares outstanding. The market capitalization of Eledon Pharmaceuticals is $73.32 million. Eledon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.82.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

Completed oversubscribed $50 million private placement First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet cell transplant...

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company will participate in the American Transplant Congress...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.82	33.7448559671	2.43	3.2884	2	257302	2.53064255	CS
4	1.14	54.028436019	2.11	3.2884	1.77	323917	2.29408035	CS
12	1.37	72.8723404255	1.88	3.2884	1.5199	173240	2.13205103	CS
26	1.96	151.937984496	1.29	3.2884	1.1099	118924	1.97700825	CS
52	1.1	51.1627906977	2.15	3.2884	1.07	106081	1.79543597	CS
156	-5.75	-63.8888888889	9	10.2	1.07	78713	3.09684155	CS
260	-12.55	-79.4303797468	15.8	22.91	1.07	76565	4.04342779	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M